Australia's most trusted
source of pharma news
Posted 22 June 2022 AM
Kate Vines, the co-founder of powerhouse patient group Rare Cancers Australia, has announced she will retire after 10 years at the helm of the organisation.
The high profile patient and patient advocate was diagnosed with the rare medullary thyroid cancer in 1991 and told she had just three months to live.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.